跳至主要内容
临床试验/KCT0003822
KCT0003822已完成未知

A 12 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of KACC91563 on atopic dermatitis in children

Aram0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
1(Year) 至 12(Year)(—)
性别
All

入选标准

  • 1) The subjects and their parents(or legal representatives), who has agreed to participate in this study and voluntarily signed the Informed consent form
  • 2) The subjects, who aged between 1 and 12 years
  • 3) The subjects, who has intermittent or continuous atopic dermatitis more than 6 months

排除标准

  • 1) The subjects with severe skin and systemic diseases other than atopic dermatitis
  • 2) The subjects, who has administered systemic antibiotics, corticosteroids, antihistamines and immunosuppressants for atopic dermatitis within 1 week before the human application test.
  • 3) The subjects, who is deemed unfit for this human application test by the Investigator

研究者

发起方
Aram

相似试验